Avident Health created by doctors to allow better teamwork in healthcare and to engage and educate patients. More teamwork leads to value: Better quality at lower cost.
2. Avident Health www.avidenthealth.com 2Proprietary and Confidential
Our Vision
To leverage mobile technology by delivering world-class
clinical decision support systems that improve patient
treatment decisions, efficient clinical collaboration and
closer patient engagement … to improve outcomes.
1- Avident Apps and cloud-based software are created by physicians working with our engineers for
cancer care teams.
2-They are designed for cancer care but can be expanded to other therapeutic areas with inherent
treatment complexities.
3- They provide collaboration tools and practice analytics.
4- We enhance patient compliance and patient outcomes through transparent engagement.
5- We increase the quality and lower the cost of health care delivery.
3. Avident Health www.avidenthealth.com 3Proprietary and Confidential
• Mobile solutions for difficult “pain points” in cancer care
•Large market opportunity in the $150 Billion cancer
treatment market
•Unique solutions without significant competition
•A team with the necessary expertise to deliver medical,
technical and business success
•A fully functional product delivered under cost and in record
time: The Accord App
•Designs in place for a mobile virtual perpetual tumor board
and a relevant medical information database
•20x potential return on investment
The Avident Opportunity
4. Avident Health www.avidenthealth.com 4Proprietary and Confidential
The Problem: Reported by NAM(*) and My Professional Observations
1. Poor collaboration and teamwork: Providers practicing in Silos.
2. Very low patient engagement and education: Leads to anxiety, poor
compliance and poor decision making.
3. Inefficiency with cluttered EMRs and patient portals: Designed largely
to justify billing, legal protection and satisfy government regulation,
EMR’s have failed to improve collaboration and patient engagement.
4. Low compliance with evidence based guidelines and care variability:
Change implementation and accessibility
5. Traditional learning and change vectors have become increasingly
ineffective
• * National Academy of Medicine: http://nap.edu/18359. Delivering High-Quality Cancer Care: Charting a New Course for a
System in Crisis
5. Avident Health www.avidenthealth.com 5Proprietary and Confidential
Current Solutions Critique Avident Solution
EHRs Poor collaboration, inundated with decision
irrelevant information and patient exclusive
Our Accord App and Perpetual
Tumor Board (PTB) with focus on
decision driving data, team building
and patient facing
Patient Portals Awkward, inefficient, inundated with irrelevant
information and have largely failed
The patient will have access to the
team built around their care through
our app. This creates a real “shared
decision making” environment
Conferences, books, web
pages, other provider
education tools
Impossible to manage, challenging for the
most specialized and largely replaced by
guidelines and pathways
CDS prototype: Bringing evidence
based guidelines and pathways to
the providers’ palm at the patient
bedside
Tumor conferences Once a week, patient exclusion, requires
significant preparation, clinician time
demands
PTB allows continuous
communication focused on patient
care
Multi Disciplinary clinics
with patients
Time requirement, frequency, largely not used
because of time requirements
Patient discussion and
communication continue as new
results appear after the face to face
encounter
Why are current solutions failing? The Avident Answer
6. Avident Health www.avidenthealth.com 6Proprietary and Confidential
The Avident solution: Suite of Apps
1. Mobile collaborative teamwork environment: Accord App already in
pilot at a regional 10- hospital system. It allows case discussions,
information sharing and innovation.
2. Ongoing tumor board discussion with a patient seat in the discussion:
Perpetual Tumor Board (PTB™) with a completed prototype and
product architecture will allow ongoing treatment discussion with
patient involvement
3. Isolate and create a bank of Aggregated Decision Driving Data. This
raw data source is a driver of innovation and clinical trials in addition
to increasing efficiency while interconnecting different EHRs.
4. Bring evolving evidence based guidelines to the “patient’s bedside” in
the providers palm.
5. Use our solutions to promote innovation and reduce variability.
7. Avident Health www.avidenthealth.com 7Proprietary and Confidential
ACCORD by Avident Health: Fully Functional App
7
Secure Login Easy Access to
Latest Info
Discuss and
Collaborate
Conduct
Complex
discussions
Advanced Metrics
And Survey Results
Key Features
Simple to send information, documents, and
photos to targeted audiences.
Collaborate and discuss the information
received continuously among peers.
Advance metrics to understand how the
information is received.
Non-intrusive alerting through push
notification and SMS text messages.
User Experience
• Simple to use, with mobile-first access and
single sign-on
• Secure, HIPAA-ready
• Feel “always in touch” with your
colleagues
8. Avident Health www.avidenthealth.com 8Proprietary and Confidential
The ACCORD: Avident Fully Functional App
• 104 users with 120 content items used with an open rate of 47% and a
click rate of 29%. This is compared to 22% open rate for health email
campaigns and a click rate of 2.57%
• Accord is designed to evolve into our HIPAA compliant product to
compliment PTB™.
• The clinicians including saw most value in breast cancer case
collaboration and discussions around innovation and guideline
development.
• Division leaders and managers can use it to alert staff to new
developments, relevant information and other important news or
initiative as staff open emails with decreasing frequency.
• Accord is market ready and can be adopted by healthcare organizations,
medical groups and home health agencies among others.
9. Avident Health www.avidenthealth.com 9Proprietary and Confidential
AVIDENT PTB™/CDSS: Prototype Stage
Practice
Collaboration
Clinical
Data
Treatment
Status & Alerts
Patient
Communication
Clinical & Practice
Analytics
Key Features
Obtain individualized treatment plan – based
on diagnosis, guidelines, treatment goals
Communicate next steps in real-time
Receive dynamic alerts on nationally validated
guidelines and latest clinical trials
Analyze patient population and physician data,
to optimize compliance, workflow
User Experience
• Simple to use, with mobile-first access and
single sign-on
• Secure, HIPAA-compliant
• Interfaces with all moving parts of care plan
and treatment team
• Feel “in the driver’s seat” across the care
continuum
Secure
Sign-On
10. Avident Health www.avidenthealth.com 10Proprietary and Confidential
Potentail Market Potential For PTB™
1. 1.5 Million new cancer cases in the US annually.
2. Treatment courses lasting 6-12 months in most cases and costing an average
of $100,000.
3. The deficits identified in NAM report will accelerate. Effective teamwork and
coordination of care will be required.
4. $400/ patient spent on a course of treatment to improve efficiency, care
coordination and communication will generate a potential annual revenue of
$600M
5. All stakeholders will benefit: This will create better value and improve patient
experience : Better quality at a lower cost
6. Customers are hospital systems, payers, patients and providers
11. Avident Health www.avidenthealth.com 11Proprietary and Confidential
Health Care Providers: Better quality of care, greater decision-making
confidence, improved practice efficiency, more patient-facing time, streamlined
compliance, enhanced workflow, more referrals, better clinical outcomes
Patients: Better education, more treatment transparency, more coordinated
care, higher engagement, greater trust and satisfaction with providers – leading
to better compliance, short-term outcomes and long-term survivorship
Hospitals & Clinics: Cost savings from more efficient utilization, improved
technology and analytics, enhanced reputation in oncology care and clinical
leadership
Payers: Lower costs of care, improved adherence to guidelines, fewer
redundant tests, lower re-admissions & reoccurrences
Stakeholder Benefits
12. Avident Health www.avidenthealth.com 12Proprietary and Confidential
Vendor Focus Mobile
Technology
Patient
facing
Guideline
based
Treatment
plans
Program
Leadership
module
Critique
Cancer care Yes Yes Yes Yes Provides a complete solution
for cancer care
Cancer care No No Yes No Based around EMR. Patient
excluded. No leadership
module
Survivorship No No No No Survivorship plans
Chemotherap
y regimen
No No No No Focused on chemotherapy
regimen. Lists potential
options and their price.
Traditional
EMR
No No No No Innovative but still an EMR.
No patient facing. Not
focused on decision and
management
EMR based
CDS
No No Yes No True CDS. Not NCCN
based. Awkward guideline
development non
sustainable. RMR based
Rehab and
aftercare
No No No No No significant oncology
focus
Competition
13. Avident Health www.avidenthealth.com 13Proprietary and Confidential
OUR TEAM
DR. MAEN FARHA,
Founder, Board
Chairman and Chief
Medical Officer
STEVE WOLF
Marketing Strategy
Customer Insights
WolfWorks
BOZ BOROWIECKI
CEO
Operations
Management
TODD JENNINGS
IT Advisor &
Solution Architecture
Cyber Tiger Technologies
SAM FARHA
Software Engineer, EMR
specialist and EMR
integration
TAN LU
Software Development
& Solution Architecture
Cyber Tiger
Technologies
REDMOND FARHA
Finance, Investment
Banking & Accountancy
(CPA).
KAMEL JABBOUR
International Business
Development,
Regulation and
Government Affairs
14. Avident Health www.avidenthealth.com 14Proprietary and Confidential
• Avident Health and our team have thoroughly investigated the challenges to cancer care as
outlined by the various reports of The National Academy of Medicine (Formerly IOM).
• Identified a gap in the market through research of competitor products.
• Our Accord App will create a collaborative environment and help accelerate efficiency
gains. Feedback from the pilot suggests that it is also a great education tool.
• Our PTB™ App will bring providers out of their specialty areas and silos and facilitate
deeper engagement with patients. It will also maintain focus on the patient’s progress after
the F2F encounter is completed.
• We have put together an extensive team of professionals and skills that have delivered a
working prototype and can deliver these products with additional customization for a full
launch.
• Our ongoing relationship with Genentech and Medstar is built on the vision and passion
for helping our patients and has created a sense of urgency to educate and inform our
patients to alleviate their concerns and anxiety.
Summary